Researcher Profile

Researcher Profile

Thomas Riley III, MD, MS

Thomas Riley III, MD, MS

Professor, Department of Medicine
Division of Gastroenterology and Hepatology
Disease Teams:
Liver, Pancreas and Foregut Cancer
trr5@psu.edu

Research Interests

  • Liver
  • Therapeutics
  • Liver Diseases
  • Chronic Disease
  • Chronic Hepatitis C
  • Hepatitis C
  • Biopsy
  • Antiviral Agents
  • Fibrosis
  • Non-alcoholic Fatty Liver Disease
  • Transplants
  • Hepacivirus

Recent Publications

2020

Jung, J, Feldman, R, Kalidindi, Y & Riley, T 2020, 'Association of Direct-Acting Antiviral Therapy for Hepatitis C With After-Treatment Costs Among Medicare Beneficiaries', JAMA network open, vol. 3, no. 6, pp. e208081. https://doi.org/10.1001/jamanetworkopen.2020.8081
Kalidindi, Y, Jung, J, Feldman, R & Riley, T 2020, 'Association of Direct-Acting Antiviral Treatment With Mortality Among Medicare Beneficiaries With Hepatitis C', JAMA network open, vol. 3, no. 7, pp. e2011055. https://doi.org/10.1001/jamanetworkopen.2020.11055
Jung, J, Du, P, Feldman, R & Riley, T 2020, 'Discontinuation of new hepatitis C drugs among Medicare patients', American Journal of Managed Care, vol. 26, no. 2, pp. 84-88. https://doi.org/10.37765/ajmc.2020.42397
Jain, A, Riley, TR, Krok, KL, Schreibman, I, Karamchandani, DM, Liao, X, Tian, Y, Dohi, T & Kadry, Z 2020, 'Incidence of post-liver transplant hepatic dysfunction after sustained virologic response following direct-acting anti-hepatitis c therapy', Experimental and Clinical Transplantation, vol. 18, no. 3, pp. 345-352. https://doi.org/10.6002/ect.2018.0127

2019

Loloi, J, Patel, A, McDevitt, P, Bruno, MA & Riley, T 2019, 'How Strongly Do Physical Examination Estimates and Ultrasonographic Measurements of Liver Size Correlate? A Prospective Study', American Journal of Medicine, vol. 132, no. 1, pp. 103-108. https://doi.org/10.1016/j.amjmed.2018.09.012
Jain, A, Miller, D, Schreibman, I, Riley, TR, Krok, KL, Dohi, T, Sharma, R & Kadry, Z 2019, 'Is there increased risk of hepatocellular carcinoma recurrence in liver transplant patients with direct-acting antiviral therapy?', Hepatology International, vol. 13, no. 2, pp. 190-198. https://doi.org/10.1007/s12072-019-09930-x
Jung, J, Du, P, Feldman, R, Kong, L & Riley, T 2019, 'Racial/ethnic and socioeconomic disparities in use of direct-acting antivirals among Medicare beneficiaries with chronic hepatitis C, 2014-2016', Journal of Managed Care and Specialty Pharmacy, vol. 25, no. 11, pp. 1236-1242. https://doi.org/10.18553/jmcp.2019.25.11.1236

2018

Shike, H, Kadry, Z, Imamura-Kawasawa, Y, Greene, W, Riley, T, Nathan, HM, Hasz, RD & Jain, A 2018, 'Hepatitis C virus (HCV) RNA level in plasma and kidney tissue in HCV antibody-positive donors: Quantitative comparison', Clinical Transplantation, vol. 32, no. 9, e13358. https://doi.org/10.1111/ctr.13358
Bezinover, D, Deacutis, MF, Dalal, P, Moore, RP, Stine, J, Wang, M, Reeder, E, Hollenbeak, CS, Saner, FH, Riley III, T & Janicki, P 2019, 'Perioperative thrombotic complications associated with pediatric liver transplantation: a UNOS database evaluation', HPB, vol. 21, no. 3, pp. 370-378. https://doi.org/10.1016/j.hpb.2018.08.014

2017

Kasmari, AJ, Welch, A, Liu, G, Leslie, D, McGarrity, T & Riley, T 2017, 'Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome', American Journal of Medicine, vol. 130, no. 6, pp. 746.e1-746.e7. https://doi.org/10.1016/j.amjmed.2016.12.029

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)